Characterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressiveness

Free Radical Biology and Medicine

Volumn 43, Issue 2, 2007, Pages 202-215

  Chaiswing, Luksana ^a,b   Bourdeau Heller, Jeanne M ^a,b   Zhong, Weixiong ^a,b   Oberley, Terry D ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cell growth; Free radicals; LNCaP; PC3; Redox state

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; REACTIVE NITROGEN SPECIES;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL KINETICS; CELL STRAIN LNCAP; CELL STRAIN PC3; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NEOPLASM INVASIVENESS; OXIDATION-REDUCTION; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 34250821180     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.03.031     Document Type: Article

References (42)

1. Shibanuma M., Kuroki T., and Nose K. Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells. Oncogene 5 (1990) 1025-1032
2. Menon S.G., and Goswami P.C. A redox cycle within the cell cycle: ring in the old with the new. Oncogene 26 (2007) 1101-1109
3. Sun Y., and Oberley L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21 (1996) 335-348
4. Monteiro H.P., and Stern A. Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radic. Biol. Med. 21 (1996) 323-333
5. Engel R.H., and Evens A.M. Oxidative stress and apoptosis: a new treatment paradigm in cancer. Front. Biosci. 11 (2006) 300-312
6. Laurent A., Nicco C., Chereau C., Goulvestre C., Alexandre J., Alves A., Levy E., Goldwasser F., Panis Y., Soubrane O., Weill B., and Batteux F. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 65 (2005) 948-956
7. Landis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics, 1999. CA Cancer J. Clin. 49 (1999) 8-31
8. Li H., Kantoff P.W., Giovannucci E., Leitzmann M.F., Gaziano J.M., Stampfer M.J., and Ma J. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res. 65 (2005) 2498-2504
9. Oberley T.D., Zhong W., Szweda L.I., and Oberley L.W. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 44 (2000) 144-155
10. Bostwick D.G., Alexander E.E., Singh R., Shan A., Qian J., Santella R.M., Oberley L.W., Yan T., Zhong W., Jiang X., and Oberley T.D. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 89 (2000) 123-134
11. Kim A., Oberley L.W., and Oberley T.D. Induction of apoptosis by adenovirus-mediated manganese superoxide dismutase overexpression in SV-40-transformed human fibroblasts. Free Radic. Biol. Med. 39 (2005) 1128-1141
12. Li N., and Oberley T.D. Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle. J. Cell. Physiol. 177 (1998) 148-160
13. 2 mediate glucose deprivation-induced stress in human cancer cells. J. Biol. Chem. 280 (2005) 4254-4263
14. Zhou M., Diwu Z., Panchuk-Voloshina N., and Haugland R.P. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal. Biochem. 253 (1997) 162-168
15. Riganti C., Gazzano E., Polimeni M., Costamagna C., Bosia A., and Ghigo D. Diphenyleneiodonium inhibits the cell redox metabolism and induces oxidative stress. J. Biol. Chem. 279 (2004) 47726-47731
16. Lamson D.W., and Plaza S.M. The anticancer effects of vitamin K. Altern. Med. Rev. 8 (2003) 303-318
17. (pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry. Cytometry 41 (2000) 1-8
18. Mei S., Yao Q., Wu C., and Xu G. Determination of urinary 8-hydroxy-2′-deoxyguanosine by two approaches-capillary electrophoresis and GC/MS: an assay for in vivo oxidative DNA damage in cancer patients. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 827 (2005) 83-87
19. Trzeciak A.R., Nyaga S.G., Jaruga P., Lohani A., Dizdaroglu M., and Evans M.K. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis 25 (2004) 1359-1370
20. Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem. J. 401 (2007) 1-11
21. Halliwell B., and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 142 (2004) 231-255
22. Webber M.M., Quader S.T., Kleinman H.K., Bello-DeOcampo D., Storto P.D., Bice G., DeMendonca-Calaca W., and Williams D.E. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Prostate 47 (2001) 1-13
23. Lim H.W., Hong S., Jin W., Lim S., Kim S.J., Kang H.J., Park E.H., Ahn K., and Lim C.J. Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells. Exp. Mol. Med. 37 (2005) 497-506
24. Jung K., Seidel B., Rudolph B., Lein M., Cronauer M.V., Henke W., Hampel G., Schnorr D., and Loening S.A. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic. Biol. Med. 23 (1997) 127-133
25. Huss W.J., Gray D.R., Greenberg N.M., Mohler J.L., and Smith G.J. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res. 65 (2005) 6640-6650
26. Wang Y., Hayward S., Cao M., Thayer K., and Cunha G. Cell differentiation lineage in the prostate. Differentiation 68 (2001) 270-279
27. Lawson D.A., Xin L., Lukacs R., Xu Q., Cheng D., and Witte O.N. Prostate stem cells and prostate cancer. Cold Spring Harbor Symp. Quant. Biol. 70 (2005) 187-196
28. Chen Y., Wang J., Fraig M.M., Metcalf J., Turner W.R., Bissada N.K., Watson D.K., and Schweinfest C.W. Defects of DNA mismatch repair in human prostate cancer. Cancer Res. 61 (2001) 4112-4121
29. van Brussel J.P., Oomen M.A., Vossebeld P.J., Wiemer E.A., Sonneveld P., and Mickisch G.H. Identification of multidrug resistance-associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine. BJU Int. 93 (2004) 1333-1338
30. 2, a necessary evil for cell signaling. Science 312 (2006) 1882-1883
31. Rhee S.G., Bae Y.S., Lee S.R., and Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE 2000 (2000) PE1
32. 2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
33. Thippeswamy T., McKay J.S., Quinn J.P., and Morris R. Nitric oxide, a biological double-faced Janus-Is this good or bad?. Histol. Histopathol. 21 (2006) 445-458
34. Jadeski L.C., Hum K.O., Chakraborty C., and Lala P.K. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int. J. Cancer 86 (2000) 30-39
35. Lim S.D., Sun C., Lambeth J.D., Marshall F., Amin M., Chung L., Petros J.A., and Arnold R.S. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62 (2005) 200-207
36. Rhee S.G., Kang S.W., Jeong W., Chang T.S., Yang K.S., and Woo H.A. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17 (2005) 183-189
37. Li S., Yan T., Yang J.Q., Oberley T.D., and Oberley L.W. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res. 60 (2000) 3927-3939
38. Venkataraman S., Jiang X., Weydert C., Zhang Y., Zhang H.J., Goswami P.C., Ritchie J.M., Oberley L.W., and Buettner G.R. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 24 (2005) 77-89
39. Horoszewicz J.S., Leong S.S., Kawinski E., Karr J.P., Rosenthal H., Chu T.M., Mirand E.A., and Murphy G.P. LNCaP model of human prostatic carcinoma. Cancer Res. 43 (1983) 1809-1818
40. Kaighn M.E., Narayan K.S., Ohnuki Y., Lechner J.F., and Jones L.W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol. 17 (1979) 16-23
41. Ripple M.O., Hagopian K., Oberley T.D., Schatten H., and Weindruch R. Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications. Antioxid Redox Signal 1 (1999) 71-81
42. Bataller M., and Portugal J. Apoptosis and cell recovery in response to oxidative stress in p53-deficient prostate carcinoma cells. Arch. Biochem. Biophys. 437 (2005) 151-158